Research Papers

25 of 75 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Differences in brain changes between adults with childhood-onset epilepsy and controls: A prospective population-based …
Sillanpää M; Hermann B; Rinne JO; Parkkola R; Saarinen MM; Karrasch M; Saunavaara J; Rissanen E; Joutsa J; Shinnar S.
Acta Neurol Scand (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Neurological side effects of SARS-CoV-2 vaccinations.
Finsterer J.
Acta Neurol Scand (Unknown)
Published: 2021
1/6 Transparent
Multiple cranial nerve palsies following COVID-19 vaccination-Case report.
Manea MM; Dragoș D; Enache I; Sirbu AG; Tuta S.
Acta Neurol Scand (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Multiple sclerosis and COVID-19: The Swedish experience.
Landtblom AM; Berntsson SG; Boström I; Iacobaeus E.
Acta Neurol Scand (Unknown)
Published: 2021
1/6 Transparent
Electroencephalography of mechanically ventilated patients at high risk of delirium.
Eskioglou E; Iaquaniello C; Alvarez V; Rüegg S; Schindler K; Rossetti AO; Oddo M.
Acta Neurol Scand (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Medium-term effects of COVID-19 pandemic on epilepsy: A follow-up study.
Lallana S; Fonseca E; Restrepo JL; Quintana M; Seijo-Raposo I; Abraira L; Santamarina E; Álvarez-Sabín J; Toledo M.
Acta Neurol Scand (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Electrodiagnostic findings in patients with non-COVID-19- and COVID-19-related acute respiratory distress syndrome.
Scarpino M; Bonizzoli M; Lazzeri C; Lanzo G; Lolli F; Ciapetti M; Hakiki B; Grippo A; Peris A; NeuCOV Study Group†; Ammannati A; Baldanzi F; Bastianelli M; Bighellini A; Boccardi C; Carrai R; Cassardo A; Cossu C; Gabbanini S; Ielapi C; Martinelli C; Masi G; Mei C; Troiano S.
Acta Neurol Scand (Unknown)
Published: 2021
2/6 Transparent
The potential neurological effect of the COVID-19 vaccines: A review.
Lu L; Xiong W; Mu J; Zhang Q; Zhang H; Zou L; Li W; He L; Sander JW; Zhou D.
Acta Neurol Scand (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Epilepsy in adult patients with tuberous sclerosis complex.
Vignoli A; La Briola F; Turner K; Peron A; Vannicola C; Chiesa V; Zambrelli E; Bruschi F; Viganò I; Canevini MP.
Acta Neurol Scand (Unknown)
Published: 2021
2/6 Transparent
Epilepsy care and COVID-19: A cross-sectional online survey from Lithuania.
Puteikis K; Mameniškienė R.
Acta Neurol Scand (Unknown)
Published: 2021
2/6 Transparent
Poststroke epilepsy incidence, risk factors and treatment: German claims analysis.
Hardtstock F; Foskett N; Gille P; Joeres L; Molzan M; Wilson JC; Wilke T; Holtkamp M.
Acta Neurol Scand (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Neurological manifestations as primary presentation of COVID-19 in hospitalized patients.
Chuang DT; Aydemir S; Magda P; Thomas C; Zarnegar R.
Acta Neurol Scand (Unknown)
Published: 2021
1/6 Transparent
Identification of a pre-possible multiple system atrophy phase.
Osaki Y; Morita Y; Miyamoto Y; Ohtsuru S; Shogase T; Furushima T; Furuya H.
Acta Neurol Scand (Unknown)
Published: 2020
1/6 Transparent
Epilepsy and lockdown: A survey of patients normally attending a Spanish centre.
Conde Blanco E; Manzanares I; Centeno M; Khawaja M; Betrán O; Donaire A; Carreño M.
Acta Neurol Scand (Unknown)
Published: 2020
Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.
Gunning B; Mazurkiewicz-Bełdzińska M; Chin RFM; Bhathal H; Nortvedt C; Dunayevich E; Checketts D.
Acta Neurol Scand (Unknown)
Published: 2020
3/6 Transparent
Registered Funding Declared
Epilepsy in time of COVID-19: A survey-based study.
Fonseca E; Quintana M; Lallana S; Luis Restrepo J; Abraira L; Santamarina E; Seijo-Raposo I; Toledo M.
Acta Neurol Scand (Unknown)
Published: 2020
Eslicarbazepine acetate in post-stroke epilepsy: Clinical practice evidence from Euro-Esli.
Sales F; Chaves J; McMurray R; Loureiro R; Fernandes H; Villanueva V.
Acta Neurol Scand (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Is wearing a face mask safe for people with epilepsy?
Asadi-Pooya AA; Cross JH.
Acta Neurol Scand (Unknown)
Published: 2020
1/6 Transparent
Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials.
Devinsky O; Thiele EA; Wright S; Checketts D; Morrison G; Dunayevich E; Knappertz V.
Acta Neurol Scand (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Transcranial low-frequency pulsating electromagnetic fields (T-PEMF) as post-concussion syndrome treatment.
Miller CP; Prener M; Dissing S; Paulson OB.
Acta Neurol Scand (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Medication adherence/persistence among patients with active multiple sclerosis in Finland.
Lahdenperä S; Soilu-Hänninen M; Kuusisto HM; Atula S; Junnila J; Berglund A.
Acta Neurol Scand (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Time course of 75%-100% efficacy response of adjunctive brivaracetam.
Klein P; Laloyaux C; Elmoufti S; Gasalla T; Martin MS.
Acta Neurol Scand (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Changes in perampanel levels during de-induction: Simulations following carbamazepine discontinuation.
Schuck E; Ferry J; Gidal B; Hussein Z.
Acta Neurol Scand (Unknown)
Published: 2020
2/6 Transparent
Funding Declared
Return to work after stroke: A Swedish nationwide registry-based study.
Westerlind E; Persson HC; Eriksson M; Norrving B; Sunnerhagen KS.
Acta Neurol Scand (Unknown)
Published: 2019
2/6 Transparent
Funding Declared
Symptoms and consequences of subarachnoid haemorrhage after 7 years.
Persson HC; Törnbom M; Winsö O; Sunnerhagen KS.
Acta Neurol Scand (Unknown)
Published: 2019
2/6 Transparent
Funding Declared